Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Cell Transplantation
100%
Hematopoietic Cell
100%
Observational Study
50%
Epidermal Growth Factor Receptor
50%
Amphiregulin
50%
Epidermal Growth Factor
50%
Failure Free Survival
50%
Blood Plasma
50%
Keyphrases
Clinical Outcomes
100%
Graft-versus-host Disease (GvHD)
100%
Angiogenic Factors
100%
Late Acute
100%
Overall Survival
13%
Confidence Interval
6%
Initial Treatment
6%
New Onset
6%
Hematopoietic Cell Transplantation
6%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
6%
Clinical Course
6%
Epidermal Growth Factor
6%
Complete Response
6%
Partial Response
6%
Amphiregulin
6%
Disease Symptoms
6%
International Consortium
6%
Failure-free Survival
6%
Non-relapse Mortality
6%
Mount Sinai
6%
Epidermal Growth Factor Receptor Ligands
6%
Medicine and Dentistry
Acute Graft Versus Host Disease
100%
Angiogenic Factor
100%
Chronic Graft Versus Host Disease
36%
Overall Survival
18%
Cell Transplantation
18%
Hematopoietic Cell
18%
Epidermal Growth Factor Receptor
9%
Disease Course
9%
Observational Study
9%
Epidermal Growth Factor
9%
Failure Free Survival
9%
Amphiregulin
9%
Immunology and Microbiology
Acute Graft Versus Host Disease
100%
Angiogenic Factor
100%
Chronic Graft Versus Host Disease
36%
Hematopoietic Cell
18%
Overall Survival
18%
Epidermal Growth Factor
18%
Cell Transplantation
18%
Blood Plasma
9%
Amphiregulin
9%
Failure Free Survival
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Graft Versus Host Disease
100%
Angiogenic Factor
100%
Chronic Graft Versus Host Disease
36%
Overall Survival
18%
Epidermal Growth Factor Receptor
9%
Observational Study
9%
Disease Course
9%
Epidermal Growth Factor
9%
Failure Free Survival
9%
Amphiregulin
9%
Neuroscience
Angiogenic Factor
100%
Hematopoietic Cell
50%
Epidermal Growth Factor Receptor
25%
Epidermal Growth Factor
25%
Amphiregulin
25%
Blood Plasma
25%